Evaluating the adverse effects of melphalan formulations.

Elaine XiangJian NiBrett GlotzbeckerJacob LaubachRobert SoifferAnne M McDonnell

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2018)

There were minimal differences in tolerability or side effects observed between PG-free MEL and PG-MEL. These data may assist in better understanding the anticipated adverse effects of a high-dose melphalan conditioning therapy.

Keyphrases

high dose
stem cell transplantation
low dose
electronic health record
open label
big data
clinical trial
randomized controlled trial
stem cells
double blind
emergency department
adverse drug
data analysis
cell therapy